Region Vaesterbotten
- Address
- Köksvägen 11, 90737 Umeå, Sweden
Region Vaesterbotten - Pediatric Oncology and Sarcoma Research
Region Vaesterbotten participates in advanced international collaborative research focused on pediatric and adolescent cancers, with particular expertise in the treatment of rare bone and soft tissue malignancies. The center contributes to multi-national trials aimed at optimizing therapeutic approaches for challenging oncologic conditions.
- Ewing sarcoma treatment optimization and maintenance therapy strategies
- Radiation therapy dose optimization and toxicity management
- Primary disseminated disease management in pediatric sarcomas
The center's involvement in the iEuroEwing trial demonstrates commitment to investigating novel treatment combinations including VinoCyc maintenance therapy and evaluating optimal radiation dosing protocols. Research activities encompass both standard-risk and high-risk patient populations, with focus on improving event-free survival outcomes while minimizing treatment-related toxicities in young patients with Ewing sarcoma.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1GPOH gGmbH1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Region Vaesterbotten
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Clindamycin Hydrochloride and Drug Combination on 90-Day Mortality in Patients with Staphylococcus aureus Bacteremia | Universitair Medisch Centrum Utrecht | Phase III | Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin | 1 | Unknown | 2023-10-26 | 2023-10-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.